Therapeutics
-
Business
Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst
[ad_1] The day after Intellia Therapeutics (NTLA -0.84%) updated investors with its results for the fourth quarter on Feb. 23,…
Read More » -
Business
Why Celldex Therapeutics Blasted 13% Higher on Monday
[ad_1] Clinical-stage biotech Celldex Therapeutics (CLDX 12.97%) was a standout on the stock market Monday. The company’s share price closed…
Read More » -
Business
Axsome Therapeutics (AXSM) Q3 2023 Earnings Call Transcript
[ad_1] Image source: The Motley Fool. Axsome Therapeutics (AXSM -0.64%)Q3 2023 Earnings CallNov 06, 2023, 8:00 a.m. ET Contents: Prepared…
Read More »